1.Introduction

Light exposure may trigger drug degradation, discoloration and impurity growth. As a globally‑recognized regulation, ICH Q1B lays down mandatory rules for photostability testing, which is essential for both overseas drug registration and domestic stability research. Many laboratories face common troubles such as insufficient cumulative light dosage, non‑compliant light spectrum and audit‑failure risks. Combined with rich industry experience, Labonce explains core requirements and practical solutions to help you run photostability studies in full compliance.

2. Mandatory Cumulative‑Dose Requirements

According to ICH Q1B confirmatory studies, two cumulative‑dose targets must both be fulfilled:

a. Total visible illumination ≥ 1.2 million lux‑hours

b. Integrated near‑ultraviolet energy ≥ 200 Wh/m² (320‑400 nm)

【Note】1.2 million lux‑hours refers to cumulative total dosage, not fixed illumination value. Labs can calculate exposure time according to real‑time illumination.

3.Two Approved Light‑source Options

Two officially‑accepted light‑source options from ICH Q1B:

Option 1: D65 / ID65 daylight‑simulating lamps, such as xenon‑arc lamp.

Option 2: Combined system: cool‑white fluorescent lamp + near‑UV lamp (peak emission: 350‑370nm).

Common Pitfall: Visible‑light‑only exposure without near‑UV output will make your test invalid, even if 1.2 million lux‑hours is reached.

4. Key Practices for Accurate Cumulative‑Dose Control

Practical Guidelines

a. Real‑time cumulative dosage monitoring

Estimate by manual timing often leads to deviation. ICH‑compliant photostability chambers shall be fitted with calibrated sensors to accumulate lux‑hours & UV energy automatically, and stop testing once targets are achieved.

b. Periodic sensor calibration

Lamp aging may cause sensor drift. Calibrate illumination sensors every 6‑12 months. Chemical actinometer can be placed alongside samples for dosage verification.

c. Independent temperature control

Heat generated by lamps may cause thermal degradation. Photostability chambers should control inner temperature steadily to eliminate thermal interference.

d. Prepare dark‑control samples

Place aluminium‑foil‑covered blank samples inside the chamber to distinguish light‑induced degradation from thermal changes.

5. Four Audit-Trail Requirements for Equipment Compliance (Key Focus Areas for GMP+ and ICH Dual Verification)

Audit‑ready requirements for photostability chambers:

a. Automatically record illumination, UV energy, temperature and cumulative dosage;

b. Full audit‑trail function for all operation logs;

c. USB data export, unalterable raw data to meet ALCOA+ data‑integrity rules;

d. Lamp‑life reminder to replace aged light modules on time.

6. Conclusion

Light stability testing for pharmaceuticals is not simply a matter of turning on a light and timing the exposure. The three essential elements—**spectral matching, compliance with cumulative dose thresholds for both parameters, and full data traceability throughout the process**—are all indispensable for producing valid test results recognized by global regulatory authorities.

If you are looking for light stability test chambers or constant temperature and humidity test equipment that fully comply with ICH Q1B and the Chinese Pharmacopoeia, please visit our website to explore our complete suite of compliance solutions.

For technical consultation on selecting light exposure testing equipment, please feel free to contact the Labonce technical sales team at any time.

Labonce ------ Specializing in compliant environmental simulation testing solutions for the pharmaceutical industry